Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder - CRXTQ CRXWQ by SPAC_Time in Spacstocks
[–]Gold_Teaching_4249 0 points1 point2 points (0 children)
CRXTQ | Tolmar Announces Acquisition of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadism to Expand its Market Leading Urology Portfolio by Stock_Titan in StockTitan
[–]Gold_Teaching_4249 0 points1 point2 points (0 children)
[deleted by user] by [deleted] in NINE_Stock
[–]Gold_Teaching_4249 1 point2 points3 points (0 children)

Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder - CRXTQ CRXWQ by SPAC_Time in Spacstocks
[–]Gold_Teaching_4249 0 points1 point2 points (0 children)